Skip to content

DB Medic

Active
Private limited companyfounded 2022active for 4 yearsPathoekeweg 96, 8000 Brugge, BelgiumKBO/BCE: BE 0786.647.828
Summary

DB Medic has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €237,883 and a net result of €157,580. Equity is growing by about 146% per year across the filed financial years. Its solvency ranks better than 50% of 13,639 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€579,690total assets 2025
Equity
€237,883
Profit
€157,580
Turnover not published (micro format)
Financial health
70 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.8%
Structure
2025 accounts 6 days early1 of 2 deeds summarised
Why 70raises risk1 change of registered office in 24 monthsFounded in 2022lowers riskSize: total assets €579,690Liquidity: current ratio 1.85, cash €125,892Show the evidence

Checked score

Score 2025
70 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 75% of its sector peers (NACE 46, micro)
Financial strength · tick = 2024
Strong
Solvency 66+12
equity 41.0% of total assets
Liquidity 52-15
short-term debt 49.8% · cash 21.7%
Profitability 100=
return on assets 27.2%
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%

About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,883 companies, NACE 46, micro)
Last 24 months 11-2024: 2.5%highest value 12-2024: 2.4%▼ -0.1 percentage points vs 11-2024 01-2025: 2.4%● unchanged vs 12-2024 02-2025: 0.6%▼ -1.8 percentage points vs 01-2025 03-2025: 0.6%● unchanged vs 02-2025 04-2025: 0.6%● unchanged vs 03-2025 05-2025: 0.6%● unchanged vs 04-2025 06-2025: 0.6%● unchanged vs 05-2025 07-2025: 0.6%● unchanged vs 06-2025 08-2025: 0.6%● unchanged vs 07-2025 09-2025: 0.6%● unchanged vs 08-2025 10-2025: 0.6%● unchanged vs 09-2025 11-2025: 0.7%▲ +0.1 percentage points vs 10-2025 12-2025: 0.7%● unchanged vs 11-2025 01-2026: 0.7%● unchanged vs 12-2025 02-2026: 0.2%▼ -0.5 percentage points vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026lowest value 06-2026: 0.4%▲ +0.2 percentage points vs 05-2026 07-2026: 0.4%● unchanged vs 06-2026 08-2026: 0.4%● unchanged vs 07-2026 09-2026: 0.4%● unchanged vs 08-2026 10-2026: 0.8%▲ +0.4 percentage points vs 09-2026
Credit of up to €16,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.85, compared with 1.43 in 2024, above the usual 1.5; short-term debt: 49.8% and cash: 21.7% of total assets), but 59% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 50% on solvency, 57% on liquidity, 95% on profitability and 97% on growth.

The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
raises risk · Founded in 2022
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: total assets €579,690
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.85, cash €125,892
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 25-01-2026, 6 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
6 days early
2024
29 days early
2023
29 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 21 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 2 January (3 of the last 3 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end26-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2022.
KBO publications · our coverage
  1. Registered officeRegistered-office move · Director in…
  2. Annual accounts filedfinancial year 2025 · micro…
  3. Highest result from 2023 to 2025net €157,580 ▲103%

Financials · financial year 2025, micro format

Equity
€237,883▲ 196%
2024 · €80,304
Total assets
€579,690▲ 112%
2024 · €273,206
Net result
€157,580▲ 103%
2024 · €77,614
Working capital
€246,767▲ 284%
2024 · €64,225
Trend over the years

2023 to 2025, 3 financial years

The operating result has risen two years in a row; 2025 is 99% above 2024 and is the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€223,055 2025 Net result€157,580 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 46, Wholesale trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line202320242025
Operating result€4,017-€111,920▲ 28×€223,055▲ 99.3%
Net result€1,189within the sector's middle half-€77,614above the sector's middle half▲ 65×€157,580above the sector's middle half▲ 103%
Equity€2,689below the sector's middle half-€80,304within the sector's middle half▲ 30×€237,883above the sector's middle half▲ 196%
Total assets€129,168within the sector's middle half-€273,206within the sector's middle half▲ 112%€579,690above the sector's middle half▲ 112%
Debt€126,479-€192,902▲ 52.5%€341,807▲ 77.2%
Working capital-€17,506below the sector's middle half-€64,225within the sector's middle half€246,767above the sector's middle half▲ 284%
Solvency2.1%below the sector's middle half-29.4%within the sector's middle half▲ 27.3pp41.0%within the sector's middle half▲ 11.6pp
Current ratio0.81below the sector's middle half-1.43within the sector's middle half▲ 0.621.85within the sector's middle half▲ 0.43
Return on assets (ROA)0.9%within the sector's middle half-28.4%above the sector's middle half▲ 27.5pp27.2%above the sector's middle half▼ 1.2pp
above within below the middle half of NACE 46, Wholesale trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €579,690
Fixed assets €44,231 ▼ 24.7%
Current assets €535,459 ▲ 150%
Equity and liabilities €579,690
Equity €237,883 ▲ 196%
Debt €341,807 ▲ 77.2%
Debt's share of the balance-sheet total falls from 70.6% to 59.0%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€242,506▲
2024 · €129,452
Cash flow
€177,030▲
2024 · €95,147
Quick ratio
1.56▲
2024 · 1.24
Debt to equity
1.44▼
2024 · 2.40
ROE
66.2%▼
2024 · 96.7%
Interest coverage
19.66▼
2024 · 38.89
Debt ≤ 1 year
€288,693▲
2024 · €150,263
Debt > 1 year
€12,309▼
2024 · €24,462
Income taxes
€69,629▲
2024 · €32,449
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 3,127 companies that looked in July 2024 the way this one looks now, 0.8% went bankrupt within 24 months and 97.2% are still going.

  • Small
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.8% went bankrupt
1.9% stopped otherwise
97.2% still going

For this company itself Checked computes a bankruptcy probability of 0.8% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,475 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 3,127 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines
Balance sheet Code20242025
Assets
Total assets20/58€273,206€579,690▲
Fixed assets21/28€58,717€44,231▼
Tangible fixed assets22/27€58,717€44,231▼
Plant, machinery and equipment23€11,647€9,184▼
Furniture and vehicles24€47,070€35,047▼
Current assets29/58€214,489€535,459▲
Stocks and contracts in progress3€27,665€86,333▲
Stocks30/36€27,665€86,333▲
Amounts receivable within one year40/41€87,403€322,636▲
Trade receivables40€84,595€250,615▲
Other amounts receivable41€2,808€72,021▲
Cash at bank and in hand54/58€99,421€125,892▲
Deferred charges and accrued income490/1-€599
Equity and liabilities
Total equity and liabilities10/49€273,206€579,690▲
Equity10/15€80,304€237,883▲
Contributions10/11€1,500€1,500=
Reserves13€78,804€236,383▲
Distributable reserves133€78,804€236,383▲
Amounts payable17/49€192,902€341,807▲
Amounts payable after more than one year17€24,462€12,309▼
Financial debts170/4€24,462€12,309▼
Amounts payable within one year42/48€150,263€288,693▲
Current portion of amounts payable after more than one year42€11,998€12,153▲
Trade debts44€102,213€202,883▲
Suppliers440/4€102,213€202,883▲
Advances received on contracts in progress46€349€1,050▲
Taxes, remuneration and social security45€34,867€72,330▲
Taxes450/3€32,449€69,830▲
Remuneration and social security454/9€2,418€2,500▲
Other amounts payable47/48€836€277▼
Accrued charges and deferred income492/3€18,176€40,805▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€17,532€19,451▲
Other operating charges640/8€377€253▼
Gross operating margin9900€129,829€242,759▲
Operating profit (loss)9901€111,920€223,055▲
Financial income75/76B€1,472€16,488▲
Recurring financial income75€1,472€16,488▲
Financial charges65/66B€3,328€12,335▲
Recurring financial charges65€3,328€12,335▲
Profit (loss) for the period before taxes9903€110,063€227,208▲
Income taxes67/77€32,449€69,629▲
Profit (loss) for the period9904€77,614€157,580▲
Profit (loss) for the period to be appropriated9905€77,614€157,580▲
Appropriation of the result
Profit (loss) to be appropriated9906€77,614€157,580▲
Transfer to equity691/2€77,614€157,580▲
To other reserves6921€77,614€157,580▲

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14,697€17,532€19,451▲ 10.9%
Other operating charges640/8€504€377€253▼ 33.0%
Gross operating margin9900€19,218€129,829€242,759▲ 87.0%
Operating profit (loss)9901€4,017€111,920€223,055▲ 99.3%
Financial income75/76B€45€1,472€16,488▲ 11×
Recurring financial income75€45€1,472€16,488▲ 11×
Financial charges65/66B€1,200€3,328€12,335▲ 271%
Recurring financial charges65€1,200€3,328€12,335▲ 271%
Profit (loss) for the period before taxes9903€2,862€110,063€227,208▲ 106%
Income taxes67/77€1,673€32,449€69,629▲ 115%
Profit (loss) for the period9904€1,189€77,614€157,580▲ 103%
Profit (loss) for the period to be appropriated9905€1,189€77,614€157,580▲ 103%
Line202320242025Change
Assets
Total assets20/58€129,168€273,206€579,690▲ 112%
Fixed assets21/28€56,655€58,717€44,231▼ 24.7%
Tangible fixed assets22/27€56,655€58,717€44,231▼ 24.7%
Plant, machinery and equipment23-€11,647€9,184▼ 21.1%
Furniture and vehicles24€56,655€47,070€35,047▼ 25.5%
Current assets29/58€72,513€214,489€535,459▲ 150%
Stocks and contracts in progress3€19,786€27,665€86,333▲ 212%
Stocks30/36€19,786€27,665€86,333▲ 212%
Amounts receivable within one year40/41€49,659€87,403€322,636▲ 269%
Trade receivables40€49,633€84,595€250,615▲ 196%
Other amounts receivable41€26€2,808€72,021▲ 26×
Cash at bank and in hand54/58€3,068€99,421€125,892▲ 26.6%
Deferred charges and accrued income490/1--€599-
Equity and liabilities
Total equity and liabilities10/49€129,168€273,206€579,690▲ 112%
Equity10/15€2,689€80,304€237,883▲ 196%
Contributions10/11€1,500€1,500€1,500=
Reserves13€1,189€78,804€236,383▲ 200%
Distributable reserves133€1,189€78,804€236,383▲ 200%
Amounts payable17/49€126,479€192,902€341,807▲ 77.2%
Amounts payable after more than one year17€36,460€24,462€12,309▼ 49.7%
Financial debts170/4€36,460€24,462€12,309▼ 49.7%
Amounts payable within one year42/48€90,019€150,263€288,693▲ 92.1%
Current portion of amounts payable after more than one year42€11,845€11,998€12,153▲ 1.3%
Trade debts44€51,466€102,213€202,883▲ 98.5%
Suppliers440/4€51,466€102,213€202,883▲ 98.5%
Advances received on contracts in progress46€529€349€1,050▲ 201%
Taxes, remuneration and social security45€4,880€34,867€72,330▲ 107%
Taxes450/3€2,680€32,449€69,830▲ 115%
Remuneration and social security454/9€2,200€2,418€2,500▲ 3.4%
Other amounts payable47/48€21,299€836€277▼ 66.9%
Accrued charges and deferred income492/3-€18,176€40,805▲ 124%
Line202320242025Change
Profit (loss) for the period9904€1,189€77,614€157,580▲ 103%
+ Depreciation and write-downs630€14,697€17,532€19,451▲ 10.9%
Operating cash flow (approximation)€15,886€95,147€177,030▲ 86.1%
Investment in fixed assets (approximation)--€19,594-€4,965▲ 74.7%
Change in cash-€96,354€26,470▼ 72.5%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (3)
Financial year Type Filed Reference
30-06-2025 micro format 25-01-2026 2026-00016189
30-06-2024 micro format 02-01-2025 2025-00628784
30-06-2023 micro format 02-01-2024 2024-00543601

Similar companies · same sector, comparable size

Of the 1,869 active companies whose main activity is wholesale of pharmaceutical and medical goods (NACE 46460), figures are known for 1,125. 706 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 1 of 2 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

On 30 May 2022, DB Medic was incorporated as a private limited company.1 In 2026 the registered office moved to Brugge.2 Total assets went from €129,168 in 2023 to €579,690 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 05-05-2026
  3. 3National Bank, annual accounts 2023 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-01-2027
2026
05-05
Gazette deed Registered office
Registered-office move · Director in office3 facts ▸
  • Board meeting, 09-03-2026
  • Registered-office move, Pathoekeweg 96 unit D te 8000 Brugge
  • Director in office, Gwenny De Baets (director)
25-01
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
30-06
Financial Highest result from 2023 to 2025net €157,580 ▲103%
Operating result €223,055, net result €157,580, both a record.
30-06
Financial Equity above €200,000equity €237,883 ▲196%
A profit in every financial year since 2023 builds equity to €237,883.
02-01
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
02-01
NBB filing Annual accounts filed
financial year 2023 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded30-05-2022
Financial year end30-06
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
47120Other non-specialised retail sale
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
E-invoicing
Reachable via Peppol
Peppol ID 0208:0786647828
Also 9925:BE0786647828
Registered 13-07-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 26 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Brugge · 1 establishment unit since 2022
registered office establishment The establishment unit on the map
Ground area
1.2 ha
Building footprint
4,394 m²
Building volume
38,783 m³
2 parcels, Flanders · tallest building 14.0 m. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
DB Medic
't Walletje 60, 8300 Knokke-HeistWholesale of pharmaceutical and medical goods
since 2022unit no. 2.332.334.514
2 parcels
Flanders 2 (100%)
Cadastral parcel Region Area Buildings Height / floors
31807I0459/00D005 Flanders 1.1 ha 1 · 2,942 m² 14.0 m · 4
31039F0126/00X000 Flanders 1,705 m² 1 · 1,452 m² 10.8 m · 1
How the parcels are linked
Good to know
Both parcels match the address exactly.

Articles of association

Other provisionsOther rules from the articles that fall under none of the themes above.
1 more provision in the deed, see the deed of 05-05-2026

Read from the deeds: 1 provision, deed of 05-05-2026